feed,title,long_url,short_url
Benzinga,Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: Analyst,https://benzinga.com/analyst-ratings/analyst-color/23/12/36329418/blood-based-colorectal-cancer-crc-screening-market-likely-to-benefit-from-fdas-pane,https://da.gd/25naoq
